SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Baer who wrote (787)6/11/1997 3:39:00 PM
From: William Presti   of 1172
 
The degree of dilution you are predicting is highly unlikely. First of
all you are assuming that 70,000 shares will be sold. The 70,000 is the max they are offering. Plus, if CMTR gets the green light for Hp Chek from Astra Merck, and the FDA gets off their duff and finishes
processing the approval for AWARE, then the share price at time of conversion will probably be more favorable than it is now. So, my
expectation is that this particular move to raise additional capital might add another 2 - 4 million shares in the long run at most.

Bill

p.s. Is anyone as impressed as I that Gruntal is handling the offering? To me that is one great firm for CMTR to be doing business with. If they have confidence in Chemtrak... Hmmm.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext